Exane Derivatives Has Boosted Blackstone Group (BX) Position; Iguana Healthcare Management Raised By $3.91 Million Its Biogen (BIIB) Stake

February 23, 2018 - By Michael Collier

Iguana Healthcare Management Llc increased Biogen Inc (BIIB) stake by 166.67% reported in 2017Q3 SEC filing. Iguana Healthcare Management Llc acquired 12,500 shares as Biogen Inc (BIIB)’s stock declined 13.45%. The Iguana Healthcare Management Llc holds 20,000 shares with $6.26M value, up from 7,500 last quarter. Biogen Inc now has $60.26 billion valuation. The stock decreased 0.45% or $1.29 during the last trading session, reaching $284.81. About 2.48 million shares traded or 78.83% up from the average. Biogen Inc. (NASDAQ:BIIB) has risen 4.94% since February 23, 2017 and is uptrending. It has underperformed by 11.76% the S&P500.

Exane Derivatives increased Blackstone Group (BX) stake by 29232.5% reported in 2017Q3 SEC filing. Exane Derivatives acquired 116,930 shares as Blackstone Group (BX)’s stock declined 1.16%. The Exane Derivatives holds 117,330 shares with $3.91 million value, up from 400 last quarter. Blackstone Group now has $40.38 billion valuation. The stock decreased 0.06% or $0.02 during the last trading session, reaching $34.02. About 4.46M shares traded. The Blackstone Group L.P. (NYSE:BX) has risen 20.49% since February 23, 2017 and is uptrending. It has outperformed by 3.79% the S&P500.

Since December 13, 2017, it had 0 insider purchases, and 2 insider sales for $8.50 million activity. $7.86 million worth of The Blackstone Group L.P. (NYSE:BX) was sold by HILL J TOMILSON. $632,896 worth of The Blackstone Group L.P. (NYSE:BX) was sold by Finley John G on Wednesday, December 13.

Among 19 analysts covering The Blackstone Group L.P. (NYSE:BX), 15 have Buy rating, 0 Sell and 4 Hold. Therefore 79% are positive. The Blackstone Group L.P. had 62 analyst reports since August 9, 2015 according to SRatingsIntel. On Tuesday, August 11 the stock rating was initiated by Goldman Sachs with “Buy”. Deutsche Bank maintained The Blackstone Group L.P. (NYSE:BX) on Friday, July 21 with “Hold” rating. The firm has “Hold” rating by Deutsche Bank given on Thursday, June 16. The firm earned “Overweight” rating on Friday, January 12 by JP Morgan. The stock has “Hold” rating by J.P. Morgan on Tuesday, February 6. Deutsche Bank downgraded it to “Hold” rating and $28 target in Friday, March 11 report. The stock of The Blackstone Group L.P. (NYSE:BX) has “Outperform” rating given on Tuesday, July 25 by Morgan Stanley. The firm has “Neutral” rating by JP Morgan given on Tuesday, February 6. As per Friday, October 16, the company rating was upgraded by Oppenheimer. The company was upgraded on Monday, May 22 by Citigroup.

Exane Derivatives decreased Snap Cl.A (Call) stake by 63,937 shares to 200 valued at $8,000 in 2017Q3. It also reduced Prologis (NYSE:PLD) stake by 29,553 shares and now owns 10,845 shares. Block (H.And R.) (NYSE:HRB) was reduced too.

Investors sentiment decreased to 1.24 in Q3 2017. Its down 0.40, from 1.64 in 2017Q2. It is negative, as 29 investors sold BX shares while 155 reduced holdings. 52 funds opened positions while 177 raised stakes. 272.94 million shares or 3.67% less from 283.35 million shares in 2017Q2 were reported. Jnba Finance Advisors holds 0.03% or 4,150 shares. Timber Hill Limited Liability Co holds 7,793 shares or 0.02% of its portfolio. Camelot Portfolios Limited Com invested in 13,884 shares or 0.22% of the stock. Kcm Investment Advsr Llc reported 24,566 shares or 0.05% of all its holdings. Sadoff Invest Mgmt Ltd Liability Com invested in 0.98% or 329,750 shares. The Illinois-based Dearborn Ltd Company has invested 0.02% in The Blackstone Group L.P. (NYSE:BX). Alps Advisors Inc stated it has 0.07% of its portfolio in The Blackstone Group L.P. (NYSE:BX). Private Wealth Partners Ltd Liability Corporation accumulated 210,950 shares. Hap Trading Limited Liability Co holds 0.14% or 89,555 shares. Bessemer Group Inc Inc has invested 0% in The Blackstone Group L.P. (NYSE:BX). Next Financial Gp holds 12,498 shares or 0.11% of its portfolio. Zwj Invest Counsel accumulated 7,388 shares or 0.02% of the stock. Bridgecreek Invest Mngmt Limited Liability has 1.54% invested in The Blackstone Group L.P. (NYSE:BX) for 169,860 shares. Camarda Financial Ltd Limited Liability Company holds 5,101 shares. Dreman Value Management L L C reported 13,475 shares.

Since January 9, 2018, it had 0 insider buys, and 3 insider sales for $2.53 million activity. On Tuesday, February 20 Sandrock Alfred sold $216,956 worth of Biogen Inc. (NASDAQ:BIIB) or 743 shares. 5,832 shares valued at $1.92 million were sold by PANGIA ROBERT W on Tuesday, January 9.

Investors sentiment increased to 1.13 in Q3 2017. Its up 0.25, from 0.88 in 2017Q2. It is positive, as 59 investors sold BIIB shares while 283 reduced holdings. 96 funds opened positions while 292 raised stakes. 181.16 million shares or 0.28% more from 180.66 million shares in 2017Q2 were reported. Shamrock Asset Management Limited Co holds 0.01% in Biogen Inc. (NASDAQ:BIIB) or 40 shares. Hudock Cap Grp Limited reported 0.02% of its portfolio in Biogen Inc. (NASDAQ:BIIB). State Of Wisconsin Investment Board owns 0.32% invested in Biogen Inc. (NASDAQ:BIIB) for 348,260 shares. Culbertson A N & Communications stated it has 820 shares or 0.08% of all its holdings. Piedmont Investment Advsrs Limited Liability Company has invested 0.3% in Biogen Inc. (NASDAQ:BIIB). Guardian Life Ins Of America accumulated 480 shares or 0.02% of the stock. Rmb Cap Limited Liability Com holds 2,008 shares. Ashfield Limited Liability Co has 2,292 shares. Peapack Gladstone Finance Corporation holds 2,781 shares. Swedbank holds 0.88% or 459,484 shares. Principal Fincl Incorporated holds 0.14% or 452,536 shares in its portfolio. Renaissance Grp Ltd Liability Co owns 118,791 shares. Letko Brosseau And Associates Incorporated, a Quebec – Canada-based fund reported 217,803 shares. Retirement System Of Alabama invested in 0.26% or 161,949 shares. Alta Limited Company holds 0.04% or 1,880 shares in its portfolio.

Among 33 analysts covering Biogen Idec Inc. (NASDAQ:BIIB), 24 have Buy rating, 0 Sell and 9 Hold. Therefore 73% are positive. Biogen Idec Inc. had 113 analyst reports since July 23, 2015 according to SRatingsIntel. The firm has “Buy” rating by H.C. Wainwright given on Wednesday, July 26. The company was maintained on Thursday, January 25 by BMO Capital Markets. The stock has “Buy” rating by Credit Suisse on Wednesday, February 7. H.C. Wainwright initiated it with “Buy” rating and $380 target in Tuesday, August 11 report. The firm has “Outperform” rating by BMO Capital Markets given on Monday, November 6. As per Wednesday, December 20, the company rating was upgraded by Credit Suisse. As per Thursday, January 25, the company rating was maintained by Cowen & Co. The stock of Biogen Inc. (NASDAQ:BIIB) has “Buy” rating given on Wednesday, September 9 by Jefferies. BMO Capital Markets maintained it with “Hold” rating and $382.0 target in Friday, October 20 report. The firm has “Buy” rating by Citigroup given on Tuesday, February 7.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: